Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: Results from a prospective cohort study

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 149-155

  Bardia, Aditya ^a   Olson, Janet E ^b   Vachon, Celine M ^b   Lazovich, Deann ^c   Vierkant, Robert A ^b   Wang, Alice H ^b   Limburg, Paul J ^b   Anderson, Kristin E ^c   Cerhan, James R ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aspirin; Breast cancer; Hormone receptors; NSAIDs; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 79151483259     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1074-x     Document Type: Article

References (32)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. American Cancer Society. Breast cancer facts & figures 2009-2010. American Cancer Society, Inc., Atlanta
3. RE Harris J Beebe-Donk H Doss D Burr Doss 2005 Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review) Oncol Rep 13 559 583 1:CAS:528:DC%2BD2MXjtFans74%3D 15756426
4. J Cuzick F Otto JA Baron PH Brown J Burn P Greenwald J Jankowski C La Vecchia F Meyskens HJ Senn, et al. 2009 Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement Lancet Oncol 10 501 507 1:CAS:528:DC%2BD1MXlsVKhs78%3D 10.1016/S1470-2045(09)70035-X 19410194
5. PC Elwood AM Gallagher GG Duthie LA Mur G Morgan 2009 Aspirin, salicylates, and cancer Lancet 373 1301 1309 1:CAS:528:DC%2BD1MXktlyqtbw%3D 10.1016/S0140-6736(09)60243-9 19328542
6. AG Hudson GL Gierach F Modugno J Simpson JW Wilson RW Evans VG Vogel JL Weissfeld 2008 Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women Cancer Epidemiol Biomarkers Prev 17 680 687 1:CAS:528:DC%2BD1cXjtlKhsbc%3D 10.1158/1055-9965.EPI-07-2739 18349287 (Pubitemid 351469220)
7. MA Gates SS Tworoger AH Eliassen SA Missmer SE Hankinson 2010 Analgesic use and sex steroid hormone concentrations in postmenopausal women Cancer Epidemiol Biomarkers Prev 19 1033 1041 1:CAS:528:DC%2BC3cXksVGmt7s%3D 10.1158/1055-9965.EPI-09-0975 20332258
8. SF Marshall L Bernstein H Anton-Culver D Deapen PL Horn-Ross H Mohrenweiser D Peel R Pinder DM Purdie P Reynolds, et al. 2005 Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status J Natl Cancer Inst 97 805 812 1:CAS:528:DC%2BD2MXkvVShtbY%3D 10.1093/jnci/dji140 15928301 (Pubitemid 40909123)
9. RE Harris KK Namboodiri WB Farrar 1996 Nonsteroidal antiinflammatory drugs and breast cancer Epidemiology 7 203 205 1:STN:280:DyaK28vjtFCrsw%3D%3D 10.1097/00001648-199603000-00017 8834563 (Pubitemid 26068056)
10. PF Coogan SR Rao L Rosenberg JR Palmer BL Strom AG Zauber PD Stolley S Shapiro 1999 The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer Prev Med 29 72 76 1:CAS:528:DyaK1MXltV2hsL8%3D 10.1006/pmed.1999.0518 10446030 (Pubitemid 29406779)
11. MB Terry MD Gammon FF Zhang H Tawfik SL Teitelbaum JA Britton K Subbaramaiah AJ Dannenberg AI Neugut 2004 Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk JAMA 291 2433 2440 1:CAS:528:DC%2BD2cXksVehurk%3D 10.1001/jama.291.20.2433 15161893 (Pubitemid 38669186)
12. DM Schreinemachers RB Everson 1994 Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 138 146 1:STN:280:DyaK2c3islWmsw%3D%3D 10.1097/00001648-199403000-00003 8172988
13. E Rahme J Ghosn K Dasgupta R Rajan M Hudson 2005 Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer BMC Cancer 5 159 10.1186/1471-2407-5-159 16343343 (Pubitemid 41829857)
14. Y Zhang PF Coogan JR Palmer BL Strom L Rosenberg 2005 Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited Am J Epidemiol 162 165 170 10.1093/aje/kwi182 15972932 (Pubitemid 41373542)
15. VA Kirsh N Kreiger M Cotterchio M Sloan B Theis 2007 Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings Am J Epidemiol 166 709 716 10.1093/aje/kwm216 17660454 (Pubitemid 47347905)
16. KM Egan MJ Stampfer E Giovannucci BA Rosner GA Colditz 1996 Prospective study of regular aspirin use and the risk of breast cancer J Natl Cancer Inst 88 988 993 1:STN:280:DyaK283osFGmtQ%3D%3D 10.1093/jnci/88.14.988 8667430 (Pubitemid 26239387)
17. MJ Langman KK Cheng EA Gilman RJ Lancashire 2000 Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database BMJ 320 1642 1646 1:STN:280: DC%2BD3czhsVejsQ%3D%3D 10.1136/bmj.320.7250.1642 10856067
18. EJ Jacobs MJ Thun CJ Connell C Rodriguez SJ Henley HS Feigelson AV Patel WD Flanders EE Calle 2005 Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort Cancer Epidemiol Biomarkers Prev 14 261 264 1:CAS:528:DC%2BD2MXmsVOlsw%3D%3D 10.1158/1055-9965.EPI-05-0472 15668504 (Pubitemid 41603245)
19. TW Johnson KE Anderson D Lazovich AR Folsom 2002 Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of post-menopausal breast cancer Cancer Epidemiol Biomarkers Prev 11 1586 1591 1:CAS:528:DC%2BD3sXmsF2mug%3D%3D 12496048 (Pubitemid 34919054)
20. GL Gierach JV Lacey Jr A Schatzkin MF Leitzmann D Richesson AR Hollenbeck LA Brinton 2008 Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study Breast Cancer Res 10 R38 10.1186/bcr2089 18447943
21. NR Cook IM Lee JM Gaziano D Gordon PM Ridker JE Manson CH Hennekens JE Buring 2005 Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 47 55 1:CAS:528: DC%2BD2MXlvVKnt7Y%3D 10.1001/jama.294.1.47 15998890 (Pubitemid 41002838)
22. JK Gill G Maskarinec LR Wilkens MC Pike BE Henderson LN Kolonel 2007 Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort Am J Epidemiol 166 1150 1158 10.1093/aje/kwm195 17698973 (Pubitemid 350022753)
23. L Gallicchio K Visvanathan A Burke SC Hoffman KJ Helzlsouer 2007 Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD Int J Cancer 121 211 215 1:CAS:528:DC%2BD2sXlsVajs7Y%3D 10.1002/ijc.22656 17330846 (Pubitemid 46753870)
24. S Friis L Thomassen HT Sorensen A Tjonneland K Overvad DP Cronin-Fenton U Vogel JK McLaughlin WJ Blot JH Olsen 2008 Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study Eur J Cancer Prev 17 88 96 10.1097/CEJ.0b013e3282b6fd55 18287865 (Pubitemid 351301619)
25. AR Folsom SA Kaye RJ Prineas JD Potter SM Gapstur RB Wallace 1990 Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women Am J Epidemiol 131 794 803 1:STN:280:DyaK3c3htVShug%3D%3D 2138863
26. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF et al (2008) SEER cancer statistics review, 1975-2005. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975-2005/, based on November 2007 SEER data submission, posted to the SEER web site
27. EL Korn BI Graubard D Midthune 1997 Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale Am J Epidemiol 145 72 80 1:STN:280:DyaK2s7js1Knug%3D%3D 8982025 (Pubitemid 27009060)
28. YS Zhao S Zhu XW Li F Wang FL Hu DD Li WC Zhang X Li 2009 Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis Breast Cancer Res Treat 117 141 150 1:CAS:528:DC%2BD1MXpvFyiurY%3D 10.1007/s10549-008-0228-6 18979210
29. RE Harris RT Chlebowski RD Jackson DJ Frid JL Ascenseo G Anderson A Loar RJ Rodabough E White A McTiernan 2003 Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative Cancer Res 63 6096 6101 1:CAS:528:DC%2BD3sXnvVSitb8%3D 14522941 (Pubitemid 37187516)
30. MD Holmes WY Chen L Li E Hertzmark D Spiegelman SE Hankinson 2010 Aspirin intake and survival after breast cancer J Clin Oncol 28 1467 1472 1:CAS:528:DC%2BC3cXltFGhsLw%3D 10.1200/JCO.2009.22.7918 20159825
31. A Gonzalez-Perez LA Garcia Rodriguez R Lopez-Ridaura 2003 Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis BMC Cancer 3 28 10.1186/1471-2407-3-28 14588079 (Pubitemid 38851321)
32. H Ma Y Wang J Sullivan-Halley L Weiss RT Burkman MS Simon KE Malone BL Strom G Ursin PA Marchbanks, et al. 2009 Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev 18 2214 2220 1:CAS:528: DC%2BD1MXps1eqtL8%3D 10.1158/1055-9965.EPI-09-0301 19661080